IP Library Granted Patent US 10,683,533
Granted Patent B2
US 10,683,533 · App. 16/256,574 · Granted Jun 16, 2020

Capture reactions

Inventors: Mark Umbarger (Brookline, MA); Gregory Porreca (Cambridge, MA); Charles Towne (Shrewsbury, MA); George Church (Brookline, MA)
Assignee: Molecular Loop Biosolutions, LLC
C12Q1/6816C12Q1/6806C12Q1/6813C12Q1/6869
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,683,533
App. No.
16/256,574
Granted
Jun 16, 2020
Kind
B2
Abstract

The invention generally relates to methods of performing a capture reaction. In certain embodiments, the method involves obtaining a nucleic acid, fragmenting the nucleic acid, and capturing a target sequence on the nucleic acid fragment using a capture moiety, such as a molecular inversion probe.

Claims (17)

1. A method of improving performance of molecular inversion probe capture reactions, the method comprising:

obtaining a nucleic acid;

fragmenting the nucleic acid into a plurality of nucleic acid fragments to make a target available for capture;

introducing a plurality of molecular inversion probes (MIPs) to the plurality of nucleic acid fragments, wherein each of the plurality of MIPs hybridize to the target and captures a different one of a plurality of overlapping subregions of the target on the same strand;

circularizing the hybridized MIPs;

linearizing the circularized MIPs;

amplifying the circularized MIPs to generate amplicons; and

sequencing the amplicons.

2. The method of claim 1 , further comprising the step of denaturing the nucleic acid or at least one of the plurality of nucleic acid fragments prior to the capturing step.

3. The method of claim 1 , wherein the plurality of nucleic acid fragments are from about 5 kb to about 100 kb in length.

4. The method of claim 1 , wherein the plurality of nucleic acid fragments are from about 1 kb to about 10 kb in length.

5. The method of claim 1 , wherein the nucleic acid is selected from the group of genomic DNA, genomic RNA, whole or partial genome amplification product, high molecular weight DNA, and high molecular weight RNA.

6. The method of claim 1 , wherein the step of fragmenting comprises chemical fragmenting.

7. The method of claim 6 , wherein chemical fragmenting comprises hydrolysis.

8. The method of claim 2 , wherein the step of denaturing comprises heat-based denaturation.

9. The method of claim 1 , wherein the amplification step further comprises introducing a differentiator tag sequence to the plurality of amplicons.

10. The method of claim 1 , wherein each of the plurality of MIPs comprises at least one targeting arm, wherein the at least one targeting arm of each of the plurality of MIPs hybridizes to a different sequence of the target.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 1, 2025
From: MOLECULAR LOOP BIOSCIENCES, INC.
To: MOLECULAR LOOP CORPORATION
Reel/Frame 070698/0955 →
CHANGE OF NAME Recorded Aug 16, 2023
From: MOLECULAR LOOP BIOSOLUTIONS, LLC
To: MOLECULAR LOOP BIOSCIENCES, INC.
Reel/Frame 064614/0211 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 11, 2019
From: UMBARGER, MARK; PORRECA, GREGORY; TOWNE, CHARLES; CHURCH, GEORGE
To: GOOD START GENETICS, INC.
Reel/Frame 048861/0422 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 11, 2019
From: GOOD START GENETICS, INC.
To: MOLECULAR LOOP BIOSOLUTIONS, LLC
Reel/Frame 048861/0440 →